Search

Papamichael, Konstantinos, Gabriele Stocco, and Ainhoa Ruiz Del Agua. 2023. “Challenges in Therapeutic Drug Monitoring: Optimizing Biological Treatments in Patients With Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases.”. Therapeutic Drug Monitoring 45 (5): 579-90.

Yoosuf, Shakira, Caitlin G Barrett, Konstantinos Papamichael, Sarah E Madoff, Satya Kurada, Joshua Hansen, Jocelyn A Silvester, et al. 2022. “Pancreatic Enzyme Supplementation versus Placebo for Improvement of Gastrointestinal Symptoms in Non-Responsive Celiac Disease: A Cross-over Randomized Controlled Trial.”. Frontiers in Medicine 9: 1001879.

Brown, Jeremy R Glissen, Ava Sanayei, Samantha Proctor, Ryan Flanagan, Sarah Ballou, Paul A Bain, and Judy Nee. 2023. “Examining the Nocebo Effect in Trials of Neuromodulators for Use in Disorders of Gut-Brain Interaction.”. The American Journal of Gastroenterology 118 (4): 692-701.

Yarur, Andres J, Dermot McGovern, Maria T Abreu, Adam Cheifetz, Konstantinos Papamichail, Parakkal Deepak, Alexandra Bruss, et al. 2023. “Combination Therapy With Immunomodulators Improves the Pharmacokinetics of Infliximab But Not Vedolizumab or Ustekinumab.”. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association 21 (11): 2908-2917.e10.

Gold, Stephanie L, Loren G Rabinowitz, Laura Manning, Laurie Keefer, William Rivera-Carrero, Stephanie Stanley, Alexis Sherman, et al. 2023. “High Prevalence of Malnutrition and Micronutrient Deficiencies in Patients With Inflammatory Bowel Disease Early in Disease Course.”. Inflammatory Bowel Diseases 29 (3): 423-29.

Seika, Philippa, Jocelyn Chang, Su Min Hong, Sarah Ballou, Vikram Rangan, Chethan Ramprasad, Johanna Iturrino, et al. 2025. “Glucagon-Like Peptide-1 Receptor Agonists Are Associated With a Lower Risk of Peptic Ulcer Disease: A Nationwide Cohort Study.”. Clinical Gastroenterology and Hepatology : The Official Clinical Practice Journal of the American Gastroenterological Association.

Gade, Ajay, Alessandra Saraga, Tina Deyhim, Grace Geeganage, Adam S Cheifetz, and Konstantinos Papamichael. 2025. “Treatment Optimization of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease.”. Expert Review of Gastroenterology & Hepatology.

Brenner, Todd A, Chris Labaki, Joseph D Feuerstein, and Tyler M Berzin. 2025. “Prospective Validation of the First FDA-Approved Computer-Aided Quality (CAQ) Assessment Tool for Colonoscopy: An Initial Clinical Experience.”. The American Journal of Gastroenterology.

Gade, Ajay, Alessandra Saraga, Tina Deyhim, Grace Geeganage, Samantha Zullow, Loren G Rabinowitz, Laurie B Grossberg, Adam S Cheifetz, and Konstantinos Papamichael. 2025. “Proactive Compared to Reactive Therapeutic Drug Monitoring Is Associated With Less Treatment Failure in Patients With Inflammatory Bowel Disease Treated With Adalimumab.”. Digestive Diseases and Sciences.

Gade, Ajay, Alessandra Saraga, Alfonso Elosua, Antony Ishan, Tina Deyhim, Nathan David Vanshelboym Rothschild, Adam S Cheifetz, and Konstantinos Papamichael. 2026. “Therapeutic Drug Monitoring for De-Escalating Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease.”. Expert Review of Clinical Pharmacology 19 (2): 167-74.